These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3030547)

  • 21. Small cell lung cancer trials in the EORTC.
    van Zandwijk N; McVie JG; Dalesio O; Kirkpatrick A
    Eur J Respir Dis Suppl; 1987; 149():57-62. PubMed ID: 3034650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensive induction chemotherapy in 54 patients with small cell carcinoma of the lung.
    Abeloff MD; Ettinger DS; Order SE; Khouri N; Mellits ED; Dorschel NT; Baumgardner R
    Cancer Treat Rep; 1981; 65(7-8):639-46. PubMed ID: 6265082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of small cell lung cancer in the elderly based on a critical literature review of clinical trials.
    Sekine I; Yamamoto N; Kunitoh H; Ohe Y; Tamura T; Kodama T; Saijo N
    Cancer Treat Rev; 2004 Jun; 30(4):359-68. PubMed ID: 15145510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose etoposide for central nervous system metastases of small cell lung cancer. Preliminary results.
    Postmus PE; Haaxma-Reiche H; Sleijfer DT; Kleisbauer JP; ten Velde G; Kirkpatrick A
    Eur J Respir Dis Suppl; 1987; 149():65-71. PubMed ID: 3034652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Taxol in small-cell and non-small-cell bronchial carcinoma].
    Med Klin Suppl; 1993 Nov; 2():14. PubMed ID: 7904715
    [No Abstract]   [Full Text] [Related]  

  • 26. Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: an EBMT study.
    Perey L; Rosti G; Lange A; Pampallona S; Bosquée L; Pasini F; Humblet Y; Hamdan O; Cetto GL; Marangolo M; Leyvraz S
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S40-3. PubMed ID: 8899170
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of vindesine in patients with refractory small cell lung cancer.
    Chang AY; Witte RS; Tormey DC; Ramirez G
    Cancer Treat Rep; 1984 Nov; 68(11):1407-8. PubMed ID: 6094003
    [No Abstract]   [Full Text] [Related]  

  • 28. Combination chemotherapy and radiation therapy in lung cancer.
    Sause WT
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):72-8. PubMed ID: 8052877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second line treatment (2 LT) in small cell lung cancer (SC).
    Clerici M
    Anticancer Res; 1994; 14(1B):337-9. PubMed ID: 8166479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can weight loss at presentation predict patient outcome in lung cancer?
    Temel J
    Nat Clin Pract Oncol; 2004 Dec; 1(2):68-9. PubMed ID: 16264819
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of ifosfamide in germ cell tumors and small cell lung cancer.
    Nichols CR
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):13-7. PubMed ID: 7610394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working Party.
    Sculier JP; Bureau G; Giner V; Thiriaux J; Michel J; Berchier MC; Van Cutsem O; Küstner U; Kroll F; Mommen P
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):18-22. PubMed ID: 7846537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-intensive chemotherapy in extensive-stage small cell lung cancer.
    Fukuoka M; Masuda N; Takada M; Kodama N; Kawahara M; Furuse K
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):43-7. PubMed ID: 7512276
    [No Abstract]   [Full Text] [Related]  

  • 34. Etoposide in small cell lung cancer resistant to prior chemotherapy.
    Asbury RF; Rubins J; Bennett JM
    Cancer Treat Rep; 1983 Oct; 67(10):951-2. PubMed ID: 6313187
    [No Abstract]   [Full Text] [Related]  

  • 35. Granulocyte-macrophage colony-stimulating factor in the treatment of small cell lung cancer.
    Wolf M; Klausmann M; Havemann K
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):51-6. PubMed ID: 7801147
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase II study of vinblastine in small cell carcinoma of the lung.
    Sörenson S; Osterlind K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1983 Mar; 67(3):293-5. PubMed ID: 6299548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment intensification which includes high-dose induction improves survival of lung carcinoma patients treated by high-dose chemotherapy with hematopoietic progenitor cell rescue but does not prevent high rate of relapses.
    Tomeczko J; Pacuszko T; Napora P; Lange A
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S44-7. PubMed ID: 8899171
    [No Abstract]   [Full Text] [Related]  

  • 38. [Etoposide in the treatment of small-cell lung cancer].
    Ueoka H
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1920-4. PubMed ID: 8978798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J; Saiz García F
    Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neoadjuvant chemotherapy for lung cancer].
    Hara N; Ohta M; Motohiro A; Takeo S; Miyake J; Ohtsu Y; Yamazaki S
    Rinsho Kyobu Geka; 1987; 7(5):444-7. PubMed ID: 9301797
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.